Oct 23, 2019

Biomica will partner with the Weizmann Institute to develop a selective drug for resistant bacteria

Back to all News

Highlighted News About Biomica

Oct 21, 2024

BIO-Europe 2024

Biomica will be attending Bio Europe conference, and we’re looking forward to connecting with industry leaders and innovators. Our CEO, Dr. Elran Haber, and VP of Business Development, Mel Larrosa, will be available for meetings.

Jul 1, 2024

9th Microbiome Movement – Drug Development Summit

Dr. Elran Haber, CEO of Biomica, will be participating as a panelist at the 9th Microbiome Movement – Drug Development Summit. On July 12th at 9:30 am ET, Dr. Haber will engage in the panel discussion “Defining Innovative Clinical Strategies Conserving Spend.” This discussion will explore adaptive trial methodologies, strategic partnerships, and criteria for attracting […]